TheJakartaPost

Please Update your browser

Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.

Jakarta Post

Analysis: Challenges for Indonesia’s pharmaceutical industry in 2018

  • Nadia Kusuma Dewi

    Mandiri

Jakarta   /   Wed, June 27 2018   /  03:14 am

The prospects of Indonesia’s healthcare sector, including that of the pharmaceutical industry, are promising. The public’s growing access to healthcare services through BPJS Kesehatan’s coverage, and the increase in health awareness supported by rising incomes, are key drivers of the growth of the pharmaceutical industry. The Central Statistics Agency has recorded that large and medium sized pharmaceutical producers, chemical products and traditional medicines grew 8.95 percent year-on-year (yoy) in the first quarter, higher than the 6.29 percent yoy in the first quarter of 2017. The Association of Indonesian Pharmaceutical Companies estimated that the national pharmaceutical market in 2017 would grow 7.4 percent to Rp 72 trillion and would see even better growth in 2018. However, the pharmaceutical industry has faced several challenges in 2018. First, the regulation regarding envi...